Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
YARDLEY, Pa., May 17, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ on May 20, 2024 at 11:30 a.m. ET.
宾夕法尼亚州亚德利，2024 年 5 月 17 日（环球新闻专线）— Optinose 纳斯达克股票代码：OPTN）是一家专注于耳鼻喉科（ENT）和过敏专家治疗的患者的制药公司，今天宣布，其管理团队成员将在美国东部时间2024年5月20日上午11点30分在纳斯达克举行的H.C. Wainwright第二届年度BioConnect投资者会议上介绍公司概况和业务最新情况。
To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.
要收听演讲的网络直播，请访问Optinose网站的投资者页面。
A replay of the webcast will be available for 30 days following the conclusion of the event.
网络直播的重播将在活动结束后的30天内提供。
About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.
关于 Optinose
Optinose是一家专业制药公司，致力于满足耳鼻喉科（ENT）和过敏专家护理的患者的需求。要了解更多信息，请访问 www.optinose.com 或者关注我们 X 和 领英。
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
Optinose 投资者联系方式
乔纳森·尼利
jonathan.neely@optinose.com267.521.0531
Source: Optinose, Inc.
资料来源：Optinose, Inc.